ALYSE MARTINEZ: Open Payments
NPI 1689235343 · RIO RANCHO, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 37 payments from 20 companies in 2025. Trend: 2023 $21 · 2024 $177 · 2025 $1,031
Food & beverage: $881Education: $150
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 5 | $239 |
| SEAGEN INC. | 1 | $100 |
| Incyte Corporation | 3 | $91 |
| Janssen Biotech, Inc. | 4 | $82 |
| Celgene Corporation | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Aveo Pharmaceuticals, Inc. | 2 | $50 |
| PFIZER INC. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Exelixis Inc. | 2 | $42 |
Products named: DATROWAY, Enhertu, REBLOZYL, FOTIVDA, CABOMETYX, PROVENGE, OJJAARA, IBRANCE.
Industry payments across NM — which companies pay providers there.
